首页> 外文期刊>Oncogene >Dual role of pseudogene TMEM198B in promoting lipid metabolism and immune escape of glioma cells
【24h】

Dual role of pseudogene TMEM198B in promoting lipid metabolism and immune escape of glioma cells

机译:假基因TMEM198B在促进胶质瘤细胞脂质代谢和免疫逃逸中的双重作用

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Dysregulation of pseudogenes, enhancement of fatty acid synthesis and formation of immunosuppressive microenvironment are important factors that promote the malignant progression of glioma. It is of great significance to search for the molecular mechanism of interaction between the three and then perform targeted interference for improving the treatment of glioma. In this study, we found that pseudogene transmembrane protein 198B (TMEM198B) was highly expressed in glioma tissues and cell lines, and it could promote malignant progression of glioma by regulating lipid metabolism reprogramming and remodeling immune microenvironment. Applying the experimental methods of gene interference, lipidomics and immunology, we further confirmed that TMEM198B promoted PLAG1 like zinc finger 2 (PLAGL2) expression by mediating tri-methylation of histone H3 on lysine 4 (H3K4me3) of PLAGL2 through binding to SET domain containing 1B (SETD1B). Increased PLAGL2 could transcriptional activate ATP citrate lyase (ACLY) and ELOVL fatty acid elongase 6 (ELOVL6) expression, and then influenced the biological behaviors of glioma cells via enhancing the de novo lipogenesis and fatty acid acyl chain elongation. At the same time, TMEM198B promoted macrophages lipid accumulation and intensification of fatty acid oxidation (FAO) through glioma-derived exosomes (GDEs), further induced macrophages to M2 polarization, which subsequently facilitated immune escape of glioma cells. In conclusion, our present study clarifies that the TMEM198B/PLAGL2/ACLY/ELOVL6 pathway conducts crucial regulatory effects on the malignant progression of glioma, which provides novel targets and new ideas for molecular targeted therapy and immunotherapy of glioma.
机译:假基因失调、脂肪酸合成增强和免疫抑制微环境形成是促进胶质瘤恶性进展的重要因素。寻找三者相互作用的分子机制,进而进行靶向干扰,对改善胶质瘤的治疗具有重要意义。在这项研究中,我们发现假基因跨膜蛋白198B(TMEM198B)在胶质瘤组织和细胞系中高表达,它可以通过调节脂质代谢重编程和重塑免疫微环境来促进胶质瘤的恶性进展。运用基因干扰、脂质组学和免疫学的实验方法,进一步证实TMEM198B通过与含有1B的SET结构域(SETD1B)结合介导PLAGL2赖氨酸4(H3K4me3)上组蛋白H3的三甲基化,促进PLAG1样锌指2(PLAGL2)表达。PLAGL2的增加可以转录激活ATP柠檬酸裂解酶(ACLY)和ELOVL脂肪酸延长酶6(ELOVL6)的表达,进而通过增强从头脂肪生成和脂肪酸酰基链延伸来影响胶质瘤细胞的生物学行为。同时,TMEM198B通过胶质瘤衍生的外泌体(GDE)促进巨噬细胞脂质积累和脂肪酸氧化(FAO)的强化,进一步诱导巨噬细胞走向M2极化,进而促进胶质瘤细胞的免疫逃逸。综上所述,本研究阐明了TMEM198B/PLAGL2/ACLY/ELOVL6通路对胶质瘤恶性进展具有重要的调控作用,为胶质瘤的分子靶向治疗和免疫治疗提供了新的靶点和新思路。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号